HOME >> BIOLOGY >> NEWS
Stanford Microbiologist Receives Lifetime Achievement Award

WASHINGTON, D.C. -April 10, 1998-- Charles Yanofsky, Professor of Biological Sciences, Stanford University, has been awarded the 1998 Abbott-American Society for Microbiology (ASM) Lifetime Achievement Award. The award, which is given to honor a distinguished scientist for a lifetime of outstanding contributions in fundamental biomedical research in any of the microbiological sciences, will be presented at the General Meeting of the ASM, May 17-21, 1998 in Atlanta, Georgia.

Dr. Yanofsky, who is being recognized for his discoveries in molecular microbiology, received his M.S. and Ph.D. degrees in microbiology from Yale University.

His research verified one of the fundamental postulates of genetic chemistry and laid the foundation for the solution of the genetic code.

Dr. Yanofsky also determined the chemical structure of the six genes encoding the enzymes for protein biosynthesis and identified the precise chemical interactions between the regulatory proteins and nucleic acid sequences that regulate the output of this set of genes.

He discovered a regulatory mechanism for controlling gene expression by attenuation, a device which determines whether transcription, once initiated, produces translatable messanger ribonucleic acids or is terminated before reaching the structural genes.

He was nominated by Robert Landick, University of Wisconsin, Madison.

The American Society for Microbiology, headquartered in Washington, D.C., is the oldest and largest single biological membership organization, with over 40,000 members worldwide.


'"/>

Contact: Stacey Collins
scollins@asmusa.org
202-942-9263
American Society for Microbiology
16-Apr-1998


Page: 1

Related biology news :

1. Tiny molecules have big potential as cancer drugs, Stanford researcher believes
2. Stanford researchers findings may shed light on common, deadly birth defect
3. Leukemia stem cells identified by Stanford researchers
4. New view of leukemia cells identifies best treatment options, Stanford researchers say
5. Confidentiality of genetic databases questioned by Stanford researchers
6. Stanford researchers go from heaven to Earth in lifeguard test
7. Transplant rejection averted by simple light exposure in Stanford animal study
8. Fat cells heal skull defects in mice, Stanford research shows
9. Gene-based screen sorts cancer cases, say Stanford researchers
10. Elusive but ubiquitous microbe fingered as gum disease culprit in Stanford study
11. Sticklebacks reveal secrets to evolutionary change in Stanford study

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/22/2020)... BARBARA, Calif. (PRWEB) , ... July 21, 2020 ... ... firm driving digital transformation and innovation in technology and compliance, announces a new ... medical device companies must ensure every layer of their technology stack complies with ...
(Date:7/4/2020)... ... July 03, 2020 , ... Aesthetics Biomedical (ABM), a ... awards for not only the products and treatments developed, but also the dedicated ... RF. All the brands built by ABM have received several honors already for ...
(Date:6/28/2020)... ... June 25, 2020 , ... ... solutions for biopharmaceutical R&D, today announced that it has entered into a ... multispecific antibodies (Multiclonics®), to support their translational and clinical research strategy to ...
Breaking Biology News(10 mins):
(Date:7/10/2020)... ... 08, 2020 , ... Bode Technology, a leading ... operations through its COVID-19 testing service, Bode-CARES . Bode-CARES combines high-volume clinical ... provides a turnkey solution that includes a comprehensive collection and virus-management program ...
(Date:7/10/2020)... ... 09, 2020 , ... In most research using the zebrafish ... formation in zebrafish embryos, maintaining optical transparency to facilitate microscopic imaging. Over the ... using the zebrafish model to investigate the causes of leukaemia and its relationship ...
(Date:7/7/2020)... ... ... R3 International is now offering stem cell therapy for Alzheimers dementia in ... the patient's condition, treatment may be offered IV, intrathecal or with a combination. , ... dementia, and the incidence continues to increase as individuals live longer. There is no ...
(Date:7/1/2020)... ... June 29, 2020 , ... MedShift ... 40% in 2020, despite many obstacles created as a result of COVID-19. As ... for its partnered medical practices and medical manufacturers by expanding access to device ...
Breaking Biology Technology:
Cached News: